- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies ; volume:1 ; number:3 ; day:1 ; month:9 ; year:2019 ; pages:134-141 ; date:9.2019
Clinical hematology international ; 1, Heft 3 (1.9.2019), 134-141, 9.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.2991/chi.d.190623.001
- URN
-
urn:nbn:de:101:1-2404301318274.225218856546
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sahin, Ugur
- Beksac, Meral
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cellular immunotherapy for refractory hematological malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting immune checkpoints in hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
Targeting posttranslational modifications to treat hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting immune checkpoints in hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
Targeting posttranslational modifications to treat hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting immune checkpoints in hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting